ReP USP - Resultado da busca

Artigo de periodico
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) (2023)
Bonifácio, Lívia Pimenta ; Ramacciotti, Eduardo ; Agati, Leandro Barile ; Vilar, Fernando Crivelenti; Silva, Anna Christina Tojal da; Louzada Junior, Paulo; Fonseca, Benedito Antonio Lopes da; Souza, Hayala Cristina Cavenague de; Oliveira, Caroline Candida Carvalho de; Aguiar, Valeria Cristina Resende; Kallas, Esper Georges ; Rodrigues, Fernando Bellíssimo
Source: Revista da sociedade brasileira de medicina tropical. Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, PANDEMIAS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFÁCIO, Lívia Pimenta et al. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, v. 56, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54695. Acesso em: 11 nov. 2024.
APA
Bonifácio, L. P., Ramacciotti, E., Agati, L. B., Vilar, F. C., Silva, A. C. T. da, Louzada Junior, P., et al. (2023). Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, 56. doi:10.1590/0037-8682-0565-2022
NLM
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Vancouver
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Artigo de periodico
Understanding Sabiá virus infections (Brazilian mammarenavirus) (2022)
Nastri, Ana Catharina de Seixas Santos; Duarte Neto, Amaro Nunes; Casadio, Luciana Vilas Boas; Souza, William Marciel de; Claro, Ingra Morales; Manuli, Erika Regina; Selegatto, Gloria; Salomao, Matias Chiarastelli; Leite, Gabriel Fialkovitz; Taborda, Mariane; Almeida, Bianca Leal de; Magri, Marcello Mihailenko Chaves; Vinhole, Ana Rubia Guedes ; Perdigão Neto, Lauro Vieira; Sataki, Fatima Mitie; Guimarães, Thaís; Mendes-Correa, Maria Cássia; Mendoza, Tânia Regina Tozetto ; Fumagalli, Marcílio Jorge; Ho, Yeh Li; Silva, Camila Alves Maia da; Coletti, Thais de Moura; Jesus, Jaqueline Goes de; Romano, Camila Malta; Hill, Sarah C.; Pybus, Oliver; Pinho, João Renato Rebello; Ledesma, Felipe Lourenço; Casal, Yuri; Kanamura, Cristina Takami; Araújo, Leonardo José Tadeu de; Ferreira, Camila Santos da Silva; Guerra, Juliana Mariotti; Figueiredo, Luiz Tadeu Moraes ; Dolhnikoff, Marisa ; Faria, Nuno Rodrigues; Sabino, Ester Cerdeira ; Alves, Venancio Avancini Ferreira ; Levin, Anna Sara Shafferman
Source: Travel Medicine and Infectious Disease. Unidades: FM, FMRP, IMT
Subjects: FEBRE AMARELA, FEBRES HEMORRÁGICAS VIRAIS, TRANSMISSÃO DE DOENÇAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASTRI, Ana Catharina de Seixas Santos et al. Understanding Sabiá virus infections (Brazilian mammarenavirus). Travel Medicine and Infectious Disease, v. 48, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.tmaid.2022.102351. Acesso em: 11 nov. 2024.
APA
Nastri, A. C. de S. S., Duarte Neto, A. N., Casadio, L. V. B., Souza, W. M. de, Claro, I. M., Manuli, E. R., et al. (2022). Understanding Sabiá virus infections (Brazilian mammarenavirus). Travel Medicine and Infectious Disease, 48, 1-9. doi:10.1016/j.tmaid.2022.102351
NLM
Nastri AC de SS, Duarte Neto AN, Casadio LVB, Souza WM de, Claro IM, Manuli ER, Selegatto G, Salomao MC, Leite GF, Taborda M, Almeida BL de, Magri MMC, Vinhole ARG, Perdigão Neto LV, Sataki FM, Guimarães T, Mendes-Correa MC, Mendoza TRT, Fumagalli MJ, Ho YL, Silva CAM da, Coletti T de M, Jesus JG de, Romano CM, Hill SC, Pybus O, Pinho JRR, Ledesma FL, Casal Y, Kanamura CT, Araújo LJT de, Ferreira CS da S, Guerra JM, Figueiredo LTM, Dolhnikoff M, Faria NR, Sabino EC, Alves VAF, Levin ASS. Understanding Sabiá virus infections (Brazilian mammarenavirus) [Internet]. Travel Medicine and Infectious Disease. 2022 ; 48 1-9.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.tmaid.2022.102351
Vancouver
Nastri AC de SS, Duarte Neto AN, Casadio LVB, Souza WM de, Claro IM, Manuli ER, Selegatto G, Salomao MC, Leite GF, Taborda M, Almeida BL de, Magri MMC, Vinhole ARG, Perdigão Neto LV, Sataki FM, Guimarães T, Mendes-Correa MC, Mendoza TRT, Fumagalli MJ, Ho YL, Silva CAM da, Coletti T de M, Jesus JG de, Romano CM, Hill SC, Pybus O, Pinho JRR, Ledesma FL, Casal Y, Kanamura CT, Araújo LJT de, Ferreira CS da S, Guerra JM, Figueiredo LTM, Dolhnikoff M, Faria NR, Sabino EC, Alves VAF, Levin ASS. Understanding Sabiá virus infections (Brazilian mammarenavirus) [Internet]. Travel Medicine and Infectious Disease. 2022 ; 48 1-9.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.tmaid.2022.102351
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Source: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subjects: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 11 nov. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico
Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records (2022)
Rodrigues, Davi Silva ; Nastri, Ana Catharina de Seixas Santos ; Magri, Marcello M.; Oliveira, Maura Salaroli de ; Sabino, Ester Cerdeira ; Figueiredo, Pedro H. M. F.; Levin, Anna Sara ; Freire, Maristela P. ; Harima, Leila; Nunes, Fátima L. S.; Ferreira, João Eduardo ; Busatto, Geraldo ; Bonfa, Eloisa Silva Dutra de Oliveira ; Utiyama, Edivaldo Massazo ; Segurado, Aluisio Augusto Cotrim ; Perondi, Beatriz ; Morais, Anna M.; Montal, Amanda ; Fusco, Solange ; Fregonesi, Marjorie; Rocha, Marcelo; Marcílio, Izabel ; Rios, Izabel C; Kawano, Fabiane Y. O.; de Jesus, M. Amelia; Kallas, Esper Georges ; Marmo, Carolina; Tanaka, Clarice ; Souza, Heraldo Possolo de ; Marchini, Julio Flavio ; Carvalho, Carlos; Ferreira, Juliana C.; Guimarães, Thais ; Lazari, Carolina S.; Duarte, Alberto José da Silva; Francisco, M. Cristina P. B.; Costa, Sílvia Figueiredo
Source: BMC Medical Informatics and Decision Making. Unidades: FM, EACH, IME, FMRP
Subjects: COVID-19, SINAIS VITAIS, ANÁLISE DE SÉRIES TEMPORAIS, COMPUTAÇÃO APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Davi Silva et al. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, v. 22, n. artigo 187, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12911-022-01931-5. Acesso em: 11 nov. 2024.
APA
Rodrigues, D. S., Nastri, A. C. de S. S., Magri, M. M., Oliveira, M. S. de, Sabino, E. C., Figueiredo, P. H. M. F., et al. (2022). Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, 22( artigo 187). doi:10.1186/s12911-022-01931-5
NLM
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Vancouver
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Trabalho de evento-resumo periodico
Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) (2021)
Bonifacio, L.; Ramacciotti, E.; Agati, L.; Vilar, F.; Tojal, A.; Souza, H.; Louzada Júnior, Paulo; Fonseca, Benedito Antonio Lopes da; Lopes, R.; Kallas, Esper Georges ; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, CITOCINAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 11 nov. 2024. , 2021
APA
Bonifacio, L., Ramacciotti, E., Agati, L., Vilar, F., Tojal, A., Souza, H., et al. (2021). Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 11 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 11 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Artigo de periodico
Higher risk of death from COVID-19 in low-income and non-white populations of São Paulo, Brazil (2021)
Li, Sabrina L. ; Pereira, Rafael H. M. ; Prete Junior, Carlos Augusto ; Zarebski, Alexander E . ; Emanuel, Lucas ; Alves, Pedro J. H. ; Peixoto, Pedro S. ; Braga, Carlos Kauê V. ; Santos, Andreza Aruska de Souza ; Souza, William Marciel de ; Barbosa, Rogério J. ; Buss, Lewis Fletcher ; Mendrone Junior, Alfredo ; Almeida Neto, Cesar de ; Lombardi, Suzete Cleusa Ferreira Spina ; Salles, Nanci A. ; Marcílio, Izabel ; Wu, Chieh-Hsi ; Gouveia, Nelson da Cruz ; Nascimento, Vítor Heloiz ; Sabino, Ester Cerdeira ; Faria, Nuno Rodrigues ; Messina, Jane P
Source: BMJ Global Health. Unidades: IME, FMRP, FM, EP
Subjects: PANDEMIA, ASPECTOS SOCIOECONÔMICOS, SÃO PAULO, COVID-19, MATEMÁTICA APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LI, Sabrina L. et al. Higher risk of death from COVID-19 in low-income and non-white populations of São Paulo, Brazil. BMJ Global Health, v. 6, n. 4, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1136/bmjgh-2021-004959. Acesso em: 11 nov. 2024.
APA
Li, S. L., Pereira, R. H. M., Prete Junior, C. A., Zarebski, A. E. ., Emanuel, L., Alves, P. J. H., et al. (2021). Higher risk of death from COVID-19 in low-income and non-white populations of São Paulo, Brazil. BMJ Global Health, 6( 4), 1-11. doi:10.1136/bmjgh-2021-004959
NLM
Li SL, Pereira RHM, Prete Junior CA, Zarebski AE ., Emanuel L, Alves PJH, Peixoto PS, Braga CKV, Santos AA de S, Souza WM de, Barbosa RJ, Buss LF, Mendrone Junior A, Almeida Neto C de, Lombardi SCFS, Salles NA, Marcílio I, Wu C-H, Gouveia N da C, Nascimento VH, Sabino EC, Faria NR, Messina JP. Higher risk of death from COVID-19 in low-income and non-white populations of São Paulo, Brazil [Internet]. BMJ Global Health. 2021 ; 6( 4): 1-11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1136/bmjgh-2021-004959
Vancouver
Li SL, Pereira RHM, Prete Junior CA, Zarebski AE ., Emanuel L, Alves PJH, Peixoto PS, Braga CKV, Santos AA de S, Souza WM de, Barbosa RJ, Buss LF, Mendrone Junior A, Almeida Neto C de, Lombardi SCFS, Salles NA, Marcílio I, Wu C-H, Gouveia N da C, Nascimento VH, Sabino EC, Faria NR, Messina JP. Higher risk of death from COVID-19 in low-income and non-white populations of São Paulo, Brazil [Internet]. BMJ Global Health. 2021 ; 6( 4): 1-11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1136/bmjgh-2021-004959
Artigo de periodico
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil (2021)
Faria, Nuno Rodrigues ; Mellan, Thomas A ; Whittaker, Charles ; Claro, Ingra Morales ; Cândido, Darlan da Silva ; Mishra, Swapnil ; Crispim, Myuki A. E. ; Sales, Flavia Cristina da Silva ; Hawryluk, Iwona ; McCrone, John T. ; Hulswit, Ruben J. G. ; Franco, Lucas A. M. ; Ramundo, Mariana Severo ; De Jesus, Jaqueline Goes ; Andrade, Pamela dos Santos ; Coletti, Thais de Moura ; Ferreira, Giulia Magalhães ; Silva, Camila Alves Maia ; Manuli, Erika Regina ; Pereira, Rafael H. M. ; Peixoto, Pedro S. ; Kraemer, Moritz U. G. ; Gaburo, Nelson ; Camilo, Cecilia da C. ; Hoeltgebaum, Henrique Helfer ; Souza, William Marciel de ; Rocha, Esmenia Coelho ; de Souza, Leandro Menezes ; Pinho, Mariana Cardoso de ; Araújo, Leonardo José Tadeu de ; Malta, Frederico S. V. ; de Lima, Aline B. ; Silva, Joice do Prado ; Zauli, Danielle A. G. ; Ferreira, Alessandro Clayton de Souza ; Schnekenberg, Ricardo P. ; Laydon, Daniel J. ; Walker, Patrick G. T. ; Schlüter, Hannah M. ; dos Santos, Ana L. P. ; Vidal, Maria S. ; Del Caro, Valentina S. ; Filho, Rosinaldo M. F.; dos Santos, Helem M.; Aguiar, Renato Santana de ; Proença-Modena, José L. ; Nelson, Bruce ; Hay, James A. ; Monod, Mélodie ; Miscouridou, Xenia ; Coupland, Helen ; Sonabend, Raphael ; Vollmer, Michaela ; Gandy, Axel ; Prete Junior, Carlos Augusto ; Nascimento, Vítor Heloiz ; Suchard, Marc A.; Bowden, Thomas A. ; Pond, Sergei L. K. ; Wu, Chieh-Hsi ; Ratmann, Oliver ; Ferguson, Neil M. ; Dye, Christopher ; Loman, Nick J. ; Lemey, Philippe ; Rambaut, Andrew ; Fraiji, Nelson A. ; Carvalho, Maria do P. S. S. ; Pybus, Oliver G ; Flaxman, Seth ; Bhatt, Samir ; Sabino, Ester Cerdeira
Source: Science. Unidades: IME, EP, FM, ICMC, IMT, FSP, FMRP
Subjects: COVID-19, MANAUS, MODELOS MATEMÁTICOS, MATEMÁTICA APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, Nuno Rodrigues et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science, v. 372, n. 6544, p. 815-821, 2021Tradução . . Disponível em: https://doi.org/10.1126/science.abh2644. Acesso em: 11 nov. 2024.
APA
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Cândido, D. da S., Mishra, S., et al. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science, 372( 6544), 815-821. doi:10.1126/science.abh2644
NLM
Faria NR, Mellan TA, Whittaker C, Claro IM, Cândido D da S, Mishra S, Crispim MAE, Sales FC da S, Hawryluk I, McCrone JT, Hulswit RJG, Franco LAM, Ramundo MS, De Jesus JG, Andrade P dos S, Coletti T de M, Ferreira GM, Silva CAM, Manuli ER, Pereira RHM, Peixoto PS, Kraemer MUG, Gaburo N, Camilo C da C, Hoeltgebaum HH, Souza WM de, Rocha EC, de Souza LM, Pinho MC de, Araújo LJT de, Malta FSV, de Lima AB, Silva J do P, Zauli DAG, Ferreira AC de S, Schnekenberg RP, Laydon DJ, Walker PGT, Schlüter HM, dos Santos ALP, Vidal MS, Del Caro VS, Filho RMF, dos Santos HM, Aguiar RS de, Proença-Modena JL, Nelson B, Hay JA, Monod M, Miscouridou X, Coupland H, Sonabend R, Vollmer M, Gandy A, Prete Junior CA, Nascimento VH, Suchard MA, Bowden TA, Pond SLK, Wu C-H, Ratmann O, Ferguson NM, Dye C, Loman NJ, Lemey P, Rambaut A, Fraiji NA, Carvalho M do PSS, Pybus OG, Flaxman S, Bhatt S, Sabino EC. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil [Internet]. Science. 2021 ; 372( 6544): 815-821.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1126/science.abh2644
Vancouver
Faria NR, Mellan TA, Whittaker C, Claro IM, Cândido D da S, Mishra S, Crispim MAE, Sales FC da S, Hawryluk I, McCrone JT, Hulswit RJG, Franco LAM, Ramundo MS, De Jesus JG, Andrade P dos S, Coletti T de M, Ferreira GM, Silva CAM, Manuli ER, Pereira RHM, Peixoto PS, Kraemer MUG, Gaburo N, Camilo C da C, Hoeltgebaum HH, Souza WM de, Rocha EC, de Souza LM, Pinho MC de, Araújo LJT de, Malta FSV, de Lima AB, Silva J do P, Zauli DAG, Ferreira AC de S, Schnekenberg RP, Laydon DJ, Walker PGT, Schlüter HM, dos Santos ALP, Vidal MS, Del Caro VS, Filho RMF, dos Santos HM, Aguiar RS de, Proença-Modena JL, Nelson B, Hay JA, Monod M, Miscouridou X, Coupland H, Sonabend R, Vollmer M, Gandy A, Prete Junior CA, Nascimento VH, Suchard MA, Bowden TA, Pond SLK, Wu C-H, Ratmann O, Ferguson NM, Dye C, Loman NJ, Lemey P, Rambaut A, Fraiji NA, Carvalho M do PSS, Pybus OG, Flaxman S, Bhatt S, Sabino EC. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil [Internet]. Science. 2021 ; 372( 6544): 815-821.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1126/science.abh2644
Artigo de periodico
Clusters of SARS-CoV-2 lineage B.1.1.7 infection after vaccination with adenovirus-vectored and inactivated vaccines (2021)
Souza, William Marciel de ; Muraro, Stéfanie P.; Souza, Gabriela F.; Amorim, Mariene R.; Sesti-Costa, Renata; Mofatto, Luciana S.; Forato, Julia; Barbosa, Priscilla P.; Toledo-Teixeira, Daniel A.; Bispo-dos-Santos, Karina; Parise, Pierina L.; Brunetti, Natalia S.; Moreira, Joselia C. O.; Costa, Vitor A.; Cardozo, Daniela M.; Moretti, Maria L.; Barros-Mazon, Silvia; Marchesi, Gabriela F.; Ambrosio, Christiane; Sabino, Ester Cerdeira ; Faria, Nuno Rodrigues
Source: Viruses. Unidades: FMRP, FM
Subjects: COVID-19, VACINAS, SURTOS DE DOENÇAS, IMUNIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, William Marciel de et al. Clusters of SARS-CoV-2 lineage B.1.1.7 infection after vaccination with adenovirus-vectored and inactivated vaccines. Viruses, v. 13, n. 11, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.3390/v13112127. Acesso em: 11 nov. 2024.
APA
Souza, W. M. de, Muraro, S. P., Souza, G. F., Amorim, M. R., Sesti-Costa, R., Mofatto, L. S., et al. (2021). Clusters of SARS-CoV-2 lineage B.1.1.7 infection after vaccination with adenovirus-vectored and inactivated vaccines. Viruses, 13( 11), 1-13. doi:10.3390/v13112127
NLM
Souza WM de, Muraro SP, Souza GF, Amorim MR, Sesti-Costa R, Mofatto LS, Forato J, Barbosa PP, Toledo-Teixeira DA, Bispo-dos-Santos K, Parise PL, Brunetti NS, Moreira JCO, Costa VA, Cardozo DM, Moretti ML, Barros-Mazon S, Marchesi GF, Ambrosio C, Sabino EC, Faria NR. Clusters of SARS-CoV-2 lineage B.1.1.7 infection after vaccination with adenovirus-vectored and inactivated vaccines [Internet]. Viruses. 2021 ; 13( 11): 1-13.[citado 2024 nov. 11 ] Available from: https://doi.org/10.3390/v13112127
Vancouver
Souza WM de, Muraro SP, Souza GF, Amorim MR, Sesti-Costa R, Mofatto LS, Forato J, Barbosa PP, Toledo-Teixeira DA, Bispo-dos-Santos K, Parise PL, Brunetti NS, Moreira JCO, Costa VA, Cardozo DM, Moretti ML, Barros-Mazon S, Marchesi GF, Ambrosio C, Sabino EC, Faria NR. Clusters of SARS-CoV-2 lineage B.1.1.7 infection after vaccination with adenovirus-vectored and inactivated vaccines [Internet]. Viruses. 2021 ; 13( 11): 1-13.[citado 2024 nov. 11 ] Available from: https://doi.org/10.3390/v13112127
Artigo de periodico
Ocular adverse events following yellow fever vaccination: a case series (2021)
Pereima, Renato Rodrigues; Bonatti, Rodolfo; Crotti, Fernanda; Furtado, João Marcello Fortes ; Lopes, Marta Heloísa ; Yamamoto, Joyce Hisae; Kreuz, André Carvalho
Source: Ocular Immunology and Inflammation. Unidades: FMRP, FM
Subjects: FEBRE AMARELA, VACINAÇÃO, FÁRMACOS, VASCULITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIMA, Renato Rodrigues et al. Ocular adverse events following yellow fever vaccination: a case series. Ocular Immunology and Inflammation, 2021Tradução . . Disponível em: https://doi.org/10.1080/09273948.2021.1887279. Acesso em: 11 nov. 2024.
APA
Pereima, R. R., Bonatti, R., Crotti, F., Furtado, J. M. F., Lopes, M. H., Yamamoto, J. H., & Kreuz, A. C. (2021). Ocular adverse events following yellow fever vaccination: a case series. Ocular Immunology and Inflammation. doi:10.1080/09273948.2021.1887279
NLM
Pereima RR, Bonatti R, Crotti F, Furtado JMF, Lopes MH, Yamamoto JH, Kreuz AC. Ocular adverse events following yellow fever vaccination: a case series [Internet]. Ocular Immunology and Inflammation. 2021 ;[citado 2024 nov. 11 ] Available from: https://doi.org/10.1080/09273948.2021.1887279
Vancouver
Pereima RR, Bonatti R, Crotti F, Furtado JMF, Lopes MH, Yamamoto JH, Kreuz AC. Ocular adverse events following yellow fever vaccination: a case series [Internet]. Ocular Immunology and Inflammation. 2021 ;[citado 2024 nov. 11 ] Available from: https://doi.org/10.1080/09273948.2021.1887279
Artigo de periodico
In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19 (2021)
Caten, Felipe Ten ; Dias, Patricia Gonzalez ; Castro, Icaro; Ogava, Rodrigo Luiz Tomio; Giddaluru, Jeevan ; Silva, Juan Carlo Santos e ; Martins, Felipe; Gonçalves, André Nicolau Aquime ; Martins, André Guilherme da Costa; Araújo, José Deney A ; Viegas, Ana Carolina Nakaya ; Cunha, Fernando de Queiroz ; Farsky, Sandra Helena Poliselli ; Bozza, Fernando A; Levin, Anna Sara Shafferman ; Pannaraj, Pia S ; Silva, Thushan I. de; Minoprio, Paola; Silva, Fabiano Pinheiro da; Andrade, Bruno B; Nakaya, Helder Takashi Imoto
Source: International Journal of Infectious Diseases. Unidades: FCF, FM, FMRP, BIOINFORMÁTICA
Subjects: COVID-19, NEUTRÓFILOS, TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA, IDADE, SEXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATEN, Felipe Ten et al. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. International Journal of Infectious Diseases, v. 105, p. 579–587, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2021.03.016. Acesso em: 11 nov. 2024.
APA
Caten, F. T., Dias, P. G., Castro, I., Ogava, R. L. T., Giddaluru, J., Silva, J. C. S. e, et al. (2021). In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. International Journal of Infectious Diseases, 105, 579–587. doi:10.1016/j.ijid.2021.03.016
NLM
Caten FT, Dias PG, Castro I, Ogava RLT, Giddaluru J, Silva JCS e, Martins F, Gonçalves ANA, Martins AG da C, Araújo JDA, Viegas ACN, Cunha F de Q, Farsky SHP, Bozza FA, Levin ASS, Pannaraj PS, Silva TI de, Minoprio P, Silva FP da, Andrade BB, Nakaya HTI. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19 [Internet]. International Journal of Infectious Diseases. 2021 ; 105 579–587.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ijid.2021.03.016
Vancouver
Caten FT, Dias PG, Castro I, Ogava RLT, Giddaluru J, Silva JCS e, Martins F, Gonçalves ANA, Martins AG da C, Araújo JDA, Viegas ACN, Cunha F de Q, Farsky SHP, Bozza FA, Levin ASS, Pannaraj PS, Silva TI de, Minoprio P, Silva FP da, Andrade BB, Nakaya HTI. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19 [Internet]. International Journal of Infectious Diseases. 2021 ; 105 579–587.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ijid.2021.03.016
Artigo de periodico
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil (2020)
Souza, William Marciel de ; Buss, Lewis Fletcher; Candido, Darlan da Silva; Carrera, Jean-Paul; Li, Sabrina; Zarebski, Alexander E; Pereira, Rafael Henrique Moraes; Prete Junior, Carlos A; Gouveia, Nelson da Cruz ; Sabino, Ester Cerdeira
Source: Nature human behaviour. Unidades: FMRP, FM
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, TRANSMISSÃO DE DOENÇAS, INFLUÊNCIAS SOCIAIS, PNEUMONIA, MORTALIDADE, FATORES SOCIOECONÔMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, William Marciel de et al. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nature human behaviour, v. 4, n. 8, p. 856-865, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41562-020-0928-4. Acesso em: 11 nov. 2024.
APA
Souza, W. M. de, Buss, L. F., Candido, D. da S., Carrera, J. -P., Li, S., Zarebski, A. E., et al. (2020). Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nature human behaviour, 4( 8), 856-865. doi:10.1038/s41562-020-0928-4
NLM
Souza WM de, Buss LF, Candido D da S, Carrera J-P, Li S, Zarebski AE, Pereira RHM, Prete Junior CA, Gouveia N da C, Sabino EC. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil [Internet]. Nature human behaviour. 2020 ; 4( 8): 856-865.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41562-020-0928-4
Vancouver
Souza WM de, Buss LF, Candido D da S, Carrera J-P, Li S, Zarebski AE, Pereira RHM, Prete Junior CA, Gouveia N da C, Sabino EC. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil [Internet]. Nature human behaviour. 2020 ; 4( 8): 856-865.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41562-020-0928-4
Artigo de jornal-dep/entr
O valor da ciência a partir do novo coronavírus: o que pensam especialistas. [Depoimento a Gabriela Brumatti e Marcelo Ferri] (2020)
Sabino, Ester Cerqueira ; Iamarino, Atila ; Oliva, Glaucius ; Damaso, Clarissa; Vieira, André; Calado, Rodrigo Tocantins
Source: Terra da Gente. Unidades: FM, IFSC, FMRP
Subjects: PESQUISA CIENTÍFICA, CORONAVIRUS, CIÊNCIA (ESTUDO E ENSINO;DISSEMINAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABINO, Ester Cerqueira et al. O valor da ciência a partir do novo coronavírus: o que pensam especialistas. [Depoimento a Gabriela Brumatti e Marcelo Ferri]. Terra da Gente. Campinas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://g1.globo.com/sp/campinas-regiao/terra-da-gente/noticia/2020/04/21/o-valor-da-ciencia-a-partir-do-novo-coronavirus-o-que-pensam-especialistas.ghtml. Acesso em: 11 nov. 2024. , 2020
APA
Sabino, E. C., Iamarino, A. , Oliva, G., Damaso, C., Vieira, A., & Calado, R. T. (2020). O valor da ciência a partir do novo coronavírus: o que pensam especialistas. [Depoimento a Gabriela Brumatti e Marcelo Ferri]. Terra da Gente. Campinas: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://g1.globo.com/sp/campinas-regiao/terra-da-gente/noticia/2020/04/21/o-valor-da-ciencia-a-partir-do-novo-coronavirus-o-que-pensam-especialistas.ghtml
NLM
Sabino EC, Iamarino A , Oliva G, Damaso C, Vieira A, Calado RT. O valor da ciência a partir do novo coronavírus: o que pensam especialistas. [Depoimento a Gabriela Brumatti e Marcelo Ferri] [Internet]. Terra da Gente. 2020 ;[citado 2024 nov. 11 ] Available from: https://g1.globo.com/sp/campinas-regiao/terra-da-gente/noticia/2020/04/21/o-valor-da-ciencia-a-partir-do-novo-coronavirus-o-que-pensam-especialistas.ghtml
Vancouver
Sabino EC, Iamarino A , Oliva G, Damaso C, Vieira A, Calado RT. O valor da ciência a partir do novo coronavírus: o que pensam especialistas. [Depoimento a Gabriela Brumatti e Marcelo Ferri] [Internet]. Terra da Gente. 2020 ;[citado 2024 nov. 11 ] Available from: https://g1.globo.com/sp/campinas-regiao/terra-da-gente/noticia/2020/04/21/o-valor-da-ciencia-a-partir-do-novo-coronavirus-o-que-pensam-especialistas.ghtml
Artigo de periodico
Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children (2019)
Wilder-Smith, Annelies; Wei, Yinghui; Araújo, Thalia Velho Barreto de; VanKerkhove, Maria; Martelli, Celina Maria Turchi; Turchi, Marília Dalva; Teixeira, Mauro; Tami, Adriana; Souza, João Paulo Dias de ; Sousa, Patricia; Duarte, Geraldo ; Silva, Vivian Helena Iida Avelino da
Source: BMJ Open. Unidades: FMRP, FM
Subjects: ZIKA VÍRUS, GRAVIDEZ, GESTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDER-SMITH, Annelies et al. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children. BMJ Open, v. 18, n. 9, p. art. e026092[17] , 2019Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2018-026092. Acesso em: 11 nov. 2024.
APA
Wilder-Smith, A., Wei, Y., Araújo, T. V. B. de, VanKerkhove, M., Martelli, C. M. T., Turchi, M. D., et al. (2019). Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children. BMJ Open, 18( 9), art. e026092[17] . doi:10.1136/bmjopen-2018-026092
NLM
Wilder-Smith A, Wei Y, Araújo TVB de, VanKerkhove M, Martelli CMT, Turchi MD, Teixeira M, Tami A, Souza JPD de, Sousa P, Duarte G, Silva VHIA da. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children [Internet]. BMJ Open. 2019 ; 18( 9): art. e026092[17] .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1136/bmjopen-2018-026092
Vancouver
Wilder-Smith A, Wei Y, Araújo TVB de, VanKerkhove M, Martelli CMT, Turchi MD, Teixeira M, Tami A, Souza JPD de, Sousa P, Duarte G, Silva VHIA da. Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children [Internet]. BMJ Open. 2019 ; 18( 9): art. e026092[17] .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1136/bmjopen-2018-026092
Artigo de periodico
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) (2018)
Nunes, Maria Carmo P; Sabino, Ester Cerdeira; Marin Neto, José Antonio; Simões, Marcus Vinícius; Schmidt, Andre
Source: European heart journal-cardiovascular imaging. Unidades: FM, FMRP
Subjects: TOMADA DE DECISÃO, DOENÇA DE CHAGAS, MIOCARDIOPATIA CONGESTIVA, ECOCARDIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Maria Carmo P et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). European heart journal-cardiovascular imaging, v. 19, n. 4, p. 459-460, 2018Tradução . . Disponível em: https://doi.org/10.1093/ehjci/jex154. Acesso em: 11 nov. 2024.
APA
Nunes, M. C. P., Sabino, E. C., Marin Neto, J. A., Simões, M. V., & Schmidt, A. (2018). Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). European heart journal-cardiovascular imaging, 19( 4), 459-460. doi:10.1093/ehjci/jex154
NLM
Nunes MCP, Sabino EC, Marin Neto JA, Simões MV, Schmidt A. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) [Internet]. European heart journal-cardiovascular imaging. 2018 ; 19( 4): 459-460.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/ehjci/jex154
Vancouver
Nunes MCP, Sabino EC, Marin Neto JA, Simões MV, Schmidt A. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) [Internet]. European heart journal-cardiovascular imaging. 2018 ; 19( 4): 459-460.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/ehjci/jex154
Artigo de periodico
Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus (2017)
Grando, Aline Vitali; Martinelli, Ana de Lourdes Candolo; Correa, Maria Cássia Jacintho Mendes
Source: Revista do Instituto de Medicina Tropical de Sao Paulo. Unidades: FM, FMRP
Subjects: HEPATITE C, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRANDO, Aline Vitali e MARTINELLI, Ana de Lourdes Candolo e CORREA, Maria Cássia Jacintho Mendes. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de Sao Paulo, v. 59, 2017Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946201759067. Acesso em: 11 nov. 2024.
APA
Grando, A. V., Martinelli, A. de L. C., & Correa, M. C. J. M. (2017). Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de Sao Paulo, 59. doi:10.1590/S1678-9946201759067
NLM
Grando AV, Martinelli A de LC, Correa MCJM. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus [Internet]. Revista do Instituto de Medicina Tropical de Sao Paulo. 2017 ; 59[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/S1678-9946201759067
Vancouver
Grando AV, Martinelli A de LC, Correa MCJM. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus [Internet]. Revista do Instituto de Medicina Tropical de Sao Paulo. 2017 ; 59[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/S1678-9946201759067
Trabalho de evento-resumo periodico
Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis (2016)
Pessoa, Mario G.; Ramalho, José Valdez Madruga; Alves, Katia; Cohen, Daniel E.; Nunes, Estevao Portela; Cheinquer, Hugo; Brandão-Mello, Carlos E.; Mendes-Côrrea, Maria Cássia Jacintho; Ferraz, Maria Lucia G.; Lari, Sara; Lui, Li; Tripathi, Rakesh; Pilot-Matias, Tami; Schulman, Nancy; Martinelli, Ana de Lourdes Candolo
Source: Hepatology. Conference titles: Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Unidades: FMRP, FM
Subjects: HEPATITE C, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PESSOA, Mario G. et al. Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis. Hepatology. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hep.28800. Acesso em: 11 nov. 2024. , 2016
APA
Pessoa, M. G., Ramalho, J. V. M., Alves, K., Cohen, D. E., Nunes, E. P., Cheinquer, H., et al. (2016). Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis. Hepatology. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hep.28800
NLM
Pessoa MG, Ramalho JVM, Alves K, Cohen DE, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Côrrea MCJ, Ferraz MLG, Lari S, Lui L, Tripathi R, Pilot-Matias T, Schulman N, Martinelli A de LC. Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis [Internet]. Hepatology. 2016 ; 64 949A-950A.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/hep.28800
Vancouver
Pessoa MG, Ramalho JVM, Alves K, Cohen DE, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Côrrea MCJ, Ferraz MLG, Lari S, Lui L, Tripathi R, Pilot-Matias T, Schulman N, Martinelli A de LC. Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis [Internet]. Hepatology. 2016 ; 64 949A-950A.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/hep.28800
Artigo de periodico
The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study (2015)
Ferreira, Paulo Roberto Abrão; Silva, Mariliza Henrique da; Brandão-Melo, Carlos Eduardo; Rezende, Rosamar Eulira; Gonzalez, Mário; Reuter, Tânia; Urbaez, Jose David; Gianini, Reinaldo Jose; Martinelli, Ana; Mendes-Corrêa, Maria Cássia
Source: Brazilian Journal of Infectious Diseases. Unidades: FM, FMRP
Subjects: HEPATITE C (TERAPIA), INTERFERONS, INFECÇÕES OPORTUNISTAS, HEPATITE CRÔNICA (TERAPIA), ANITIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Paulo Roberto Abrão et al. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, v. 19, n. 1, p. 15-22, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bjid.2014.08.002. Acesso em: 11 nov. 2024.
APA
Ferreira, P. R. A., Silva, M. H. da, Brandão-Melo, C. E., Rezende, R. E., Gonzalez, M., Reuter, T., et al. (2015). The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, 19( 1), 15-22. doi:10.1016/j.bjid.2014.08.002
NLM
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002
Vancouver
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002
Trabalho de evento-resumo periodico
The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008) (2011)
Luquetti, A.; Passos, Afonso Dinis Costa; Silveira, A. C.; Ferreira, Antônio Walter; Macedo, V.; Prata, A.
Source: Journal of Epidemiology and Community Health. Conference titles: IEA World Congress of Epidemiology. Unidades: FMRP, FM
Assunto: DOENÇA DE CHAGAS (TRANSMISSÃO;CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUQUETTI, A. et al. The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008). Journal of Epidemiology and Community Health. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2011
APA
Luquetti, A., Passos, A. D. C., Silveira, A. C., Ferreira, A. W., Macedo, V., & Prata, A. (2011). The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008). Journal of Epidemiology and Community Health. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Luquetti A, Passos ADC, Silveira AC, Ferreira AW, Macedo V, Prata A. The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008). Journal of Epidemiology and Community Health. 2011 ; 65 A43.[citado 2024 nov. 11 ]
Vancouver
Luquetti A, Passos ADC, Silveira AC, Ferreira AW, Macedo V, Prata A. The national survey of seroprevalence for evaluation of the control of Chagas disease in Brazil (2001-2008). Journal of Epidemiology and Community Health. 2011 ; 65 A43.[citado 2024 nov. 11 ]
Artigo de periodico
Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001 (2011)
Sato, Helena K.; Sanajotta, Andrea Torres; Moraes, José Cássio; Andrade, Joelma Queiróz; Duarte, Geraldo; Cervi, Maria Célia; Curti, Sueli P.; Pannuti, Cláudio Sérgio; Milanez, Helaine; Pessoto, Mônica; Flannery, Brendan; Oselka, Gabriel W.
Source: The Journal of Infectious Diseses. Unidades: FMRP, FM
Subjects: FATORES DE RISCO, RUBÉOLA (PREVENÇÃO E CONTROLE;IMUNOLOGIA), COMPLICAÇÕES INFECCIOSAS NA GRAVIDEZ (PREVENÇÃO E CONTROLE), VACINAS VIRAIS (CONTRA-INDICAÇÃO;IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SATO, Helena K. et al. Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001. The Journal of Infectious Diseses, v. 204, n. suppl. 2, p. S737-S744, 2011Tradução . . Disponível em: https://doi.org/10.1093/infdis/jir419. Acesso em: 11 nov. 2024.
APA
Sato, H. K., Sanajotta, A. T., Moraes, J. C., Andrade, J. Q., Duarte, G., Cervi, M. C., et al. (2011). Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001. The Journal of Infectious Diseses, 204( suppl. 2), S737-S744. doi:10.1093/infdis/jir419
NLM
Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G, Cervi MC, Curti SP, Pannuti CS, Milanez H, Pessoto M, Flannery B, Oselka GW. Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001 [Internet]. The Journal of Infectious Diseses. 2011 ; 204( suppl. 2): S737-S744.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/infdis/jir419
Vancouver
Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G, Cervi MC, Curti SP, Pannuti CS, Milanez H, Pessoto M, Flannery B, Oselka GW. Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001 [Internet]. The Journal of Infectious Diseses. 2011 ; 204( suppl. 2): S737-S744.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/infdis/jir419
Artigo de periodico
O inquérito nacional de soroprevalencia de avaliação do controle da doença de Chagas no Brasil (2001-2008) (2011)
Ostermayer, Alejandro Luquetti; Passos, Afonso Dinis Costa; Silveira, Antônio Carlos; Ferreira, Antônio Walter; Macedo, Vanize; Prata, Aluízio Rosa
Source: Revista da Sociedade Brasileira de Medicina Tropical. Unidades: FMRP, FM
Subjects: DOENÇA DE CHAGAS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSTERMAYER, Alejandro Luquetti et al. O inquérito nacional de soroprevalencia de avaliação do controle da doença de Chagas no Brasil (2001-2008). Revista da Sociedade Brasileira de Medicina Tropical, v. 44, p. 108-121, 2011Tradução . . Disponível em: https://doi.org/10.1590/s0037-86822011000800015. Acesso em: 11 nov. 2024.
APA
Ostermayer, A. L., Passos, A. D. C., Silveira, A. C., Ferreira, A. W., Macedo, V., & Prata, A. R. (2011). O inquérito nacional de soroprevalencia de avaliação do controle da doença de Chagas no Brasil (2001-2008). Revista da Sociedade Brasileira de Medicina Tropical, 44, 108-121. doi:10.1590/s0037-86822011000800015
NLM
Ostermayer AL, Passos ADC, Silveira AC, Ferreira AW, Macedo V, Prata AR. O inquérito nacional de soroprevalencia de avaliação do controle da doença de Chagas no Brasil (2001-2008) [Internet]. Revista da Sociedade Brasileira de Medicina Tropical. 2011 ; 44 108-121.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/s0037-86822011000800015
Vancouver
Ostermayer AL, Passos ADC, Silveira AC, Ferreira AW, Macedo V, Prata AR. O inquérito nacional de soroprevalencia de avaliação do controle da doença de Chagas no Brasil (2001-2008) [Internet]. Revista da Sociedade Brasileira de Medicina Tropical. 2011 ; 44 108-121.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/s0037-86822011000800015

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration